id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02453373 | ,,42:48:chronic_disease | Patients receiving IV tPA > 3 hours from stroke onset | 2 | [
"Patients",
"receiving",
"IV",
"tPA",
">",
"3",
"hours",
"from",
"stroke",
"onset"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02189889 | 29:35:chronic_disease | diagnosed with preoperative anemia | 2 | [
"diagnosed",
"with",
"preoperative",
"anemia"
] | [
0,
0,
0,
2
] |
NCT02048722 | 1:12:treatment,16:30:treatment,35:47:cancer | doxorubicin or taxane therapy for angiosarcoma | 2 | [
"doxorubicin",
"or",
"taxane",
"therapy",
"for",
"angiosarcoma"
] | [
1,
0,
1,
1,
0,
3
] |
NCT02501954 | 25:53:cancer | Patients with FIGO 2009 Stage IVB endometrial cancer | 2 | [
"Patients",
"with",
"FIGO",
"2009",
"Stage",
"IVB",
"endometrial",
"cancer"
] | [
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT02519322 | 12:18:cancer | resectable tumors are defined as having no significant vascular, neural or bony involvement | 2 | [
"resectable",
"tumors",
"are",
"defined",
"as",
"having",
"no",
"significant",
"vascular",
",",
"neural",
"or",
"bony",
"involvement"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02037048 | 27:39:cancer | Patients with evidence of clinical T4b (unresectable) | 2 | [
"Patients",
"with",
"evidence",
"of",
"clinical",
"T4b",
"(",
"unresectable",
")"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT02312245 | 1:27:treatment | Vaccines and immunotherapy All of these exceptions should be confirmed with the Principal Investigator (PI) prior to registration | 2 | [
"Vaccines",
"and",
"immunotherapy",
"All",
"of",
"these",
"exceptions",
"should",
"be",
"confirmed",
"with",
"the",
"Principal",
"Investigator",
"(",
"PI",
")",
"prior",
"to",
"registration"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03135990 | 9:45:chronic_disease | Current substance use disorder or dependence as primary diagnosis | 2 | [
"Current",
"substance",
"use",
"disorder",
"or",
"dependence",
"as",
"primary",
"diagnosis"
] | [
0,
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT02437370 | 18:29:chronic_disease,86:97:chronic_disease,105:128:chronic_disease | Has known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] is detected) | 2 | [
"Has",
"known",
"active",
"hepatitis",
"B",
"(",
"e.g.",
",",
"hepatitis",
"B",
"surface",
"antigen",
"[",
"HBsAg",
"]",
"reactive",
")",
"or",
"hepatitis",
"C",
"(",
"e.g.",
",",
"hepatitis",
"C",
"virus",
"[",
"HCV",
"]",
"ribonucleic",
"acid",
"[",
... | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03157713 | 6:13:chronic_disease,,,, | With obesity, based on BMI of 30 to 40 kg/m2 during a prior visit in the past 6 months | 2 | [
"With",
"obesity",
",",
"based",
"on",
"BMI",
"of",
"30",
"to",
"40",
"kg/m2",
"during",
"a",
"prior",
"visit",
"in",
"the",
"past",
"6",
"months"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02473250 | 1:4:treatment, | ECT within the past 6 months | 2 | [
"ECT",
"within",
"the",
"past",
"6",
"months"
] | [
1,
0,
0,
0,
0,
0
] |
NCT01481974 | 6:31:chronic_disease | Have fulminant hepatic failure | 2 | [
"Have",
"fulminant",
"hepatic",
"failure"
] | [
0,
2,
2,
2
] |
NCT02424955 | 22:33:cancer,37:47:cancer,62:103:treatment | Patient with primary liver tumor or metastasis scheduled for Stereotactic Ablative Radiotherapy (SABR) | 2 | [
"Patient",
"with",
"primary",
"liver",
"tumor",
"or",
"metastasis",
"scheduled",
"for",
"Stereotactic",
"Ablative",
"Radiotherapy",
"(",
"SABR",
")"
] | [
0,
0,
0,
3,
3,
0,
3,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02484404 | ,,26:39:chronic_disease | NYHA Class II or greater heart failure | 2 | [
"NYHA",
"Class",
"II",
"or",
"greater",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02324582 | ,19:38:treatment,40:43:treatment,48:73:treatment | Less than 14 days post bladder biopsy, TUR, or traumatic catheterization | 2 | [
"Less",
"than",
"14",
"days",
"post",
"bladder",
"biopsy",
",",
"TUR",
",",
"or",
"traumatic",
"catheterization"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02796391 | 1:30:treatment | Clozapine (Clozaril, FazaClo) | 2 | [
"Clozapine",
"(",
"Clozaril",
",",
"FazaClo",
")"
] | [
1,
1,
1,
0,
0,
0
] |
NCT00967785 | 29:48:chronic_disease | Signs or symptoms of active microbial infection | 2 | [
"Signs",
"or",
"symptoms",
"of",
"active",
"microbial",
"infection"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT01940757 | 24:37:chronic_disease,,, | Laboratory evidence of renal disease (serum creatinine greater than 1.25-times the upper reference limit, or more than trace protein or blood on urine dipstick testing) | 2 | [
"Laboratory",
"evidence",
"of",
"renal",
"disease",
"(",
"serum",
"creatinine",
"greater",
"than",
"1.25-times",
"the",
"upper",
"reference",
"limit",
",",
"or",
"more",
"than",
"trace",
"protein",
"or",
"blood",
"on",
"urine",
"dipstick",
"testing",
")"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03137771 | 1:21:cancer | Cutaneous metastasis of NSCLC | 2 | [
"Cutaneous",
"metastasis",
"of",
"NSCLC"
] | [
3,
3,
0,
0
] |
NCT01697293 | 1:24:treatment,, | Electrocardiogram (ECG) corrected QT (QTC) < 450 msec | 2 | [
"Electrocardiogram",
"(",
"ECG",
")",
"corrected",
"QT",
"(",
"QTC",
")",
"<",
"450",
"msec"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01871727 | 7:51:chronic_disease,66:77:chronic_disease,81:102:chronic_disease | Known human immunodeficiency virus (HIV) infection; known active hepatitis B or hepatitis C infection | 2 | [
"Known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection",
";",
"known",
"active",
"hepatitis",
"B",
"or",
"hepatitis",
"C",
"infection"
] | [
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0
] |
NCT01627301 | 138:142:chronic_disease | Prehypertensive and Normotensive Operation Enduring Freedom (OEF)/ Operation Iraqi Freedom (OIF)/ Operation New Dawn (OND) veterans with PTSD | 2 | [
"Prehypertensive",
"and",
"Normotensive",
"Operation",
"Enduring",
"Freedom",
"(",
"OEF",
")",
"/",
"Operation",
"Iraqi",
"Freedom",
"(",
"OIF",
")",
"/",
"Operation",
"New",
"Dawn",
"(",
"OND",
")",
"veterans",
"with",
"PTSD"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02362308 | 22:37:chronic_disease | Previously diagnosed type 1 Diabetes | 2 | [
"Previously",
"diagnosed",
"type",
"1",
"Diabetes"
] | [
0,
0,
2,
2,
2
] |
NCT01815359 | 21:32:allergy_name,34:44:allergy_name,49:58:allergy_name | Patients with known floxuridine, leucovorin ,or mitomycin allergy | 2 | [
"Patients",
"with",
"known",
"floxuridine",
",",
"leucovorin",
",",
"or",
"mitomycin",
"allergy"
] | [
0,
0,
0,
4,
0,
4,
0,
0,
4,
0
] |
NCT02971137 | 1:17:chronic_disease | Terminal Illness | 2 | [
"Terminal",
"Illness"
] | [
2,
2
] |
NCT02167009 | 29:47:treatment | Is considered high risk for surgical treatment | 2 | [
"Is",
"considered",
"high",
"risk",
"for",
"surgical",
"treatment"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT01625923 | 9:15:treatment | Regular opiate use | 2 | [
"Regular",
"opiate",
"use"
] | [
0,
1,
0
] |
NCT02482376 | 75:80:chronic_disease,82:102:chronic_disease,104:115:chronic_disease | Medical conditions that may increase risk for poor cosmetic outcome (i.e. Lupus, rheumatoid arthritis, scleroderma) | 2 | [
"Medical",
"conditions",
"that",
"may",
"increase",
"risk",
"for",
"poor",
"cosmetic",
"outcome",
"(",
"i.e",
".",
"Lupus",
",",
"rheumatoid",
"arthritis",
",",
"scleroderma",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
2,
0
] |
NCT01243931 | 109:112:treatment, | Patients with vision primarily limited by superficial opacities and irregularities that could be removed by PTK while leaving at least 250 µm | 2 | [
"Patients",
"with",
"vision",
"primarily",
"limited",
"by",
"superficial",
"opacities",
"and",
"irregularities",
"that",
"could",
"be",
"removed",
"by",
"PTK",
"while",
"leaving",
"at",
"least",
"250",
"µm"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01714596 | 124:155:treatment | Patients who, based upon the clinical judgment of the treating clinician, are NOT equally suited for treatment with either oral or intravenous antibiotics (i.e., those for whom there is a clinical treatment preference) | 2 | [
"Patients",
"who",
",",
"based",
"upon",
"the",
"clinical",
"judgment",
"of",
"the",
"treating",
"clinician",
",",
"are",
"NOT",
"equally",
"suited",
"for",
"treatment",
"with",
"either",
"oral",
"or",
"intravenous",
"antibiotics",
"(",
"i.e.",
",",
"those",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01174108 | 1:26:chronic_disease,30:43:chronic_disease,76:91:treatment | Major anticipated illness or organ failure incompatible with survival from PBSC transplant | 2 | [
"Major",
"anticipated",
"illness",
"or",
"organ",
"failure",
"incompatible",
"with",
"survival",
"from",
"PBSC",
"transplant"
] | [
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
1,
1
] |
NCT02157974 | 1:16:chronic_disease | Type 2 diabetes | 2 | [
"Type",
"2",
"diabetes"
] | [
2,
2,
2
] |
NCT02169089 | 1:13:chronic_disease,, | Hyperkalemia defined as serum K+≥ 5.1 meq/L at visit 0 (screening) | 2 | [
"Hyperkalemia",
"defined",
"as",
"serum",
"K+≥",
"5.1",
"meq/L",
"at",
"visit",
"0",
"(",
"screening",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03018704 | 1:14:chronic_disease | schizophrenia | 2 | [
"schizophrenia"
] | [
2
] |
NCT02373241 | 1:13:chronic_disease | Hyperkalemia | 2 | [
"Hyperkalemia"
] | [
2
] |
NCT02191488 | 61:78:cancer,72:78:cancer,104:114:cancer,119:129:cancer | Preoperative diagnosis of either presumed first-time low or high grade glioma, or recurrent glioma, or metastasis, or meningioma | 2 | [
"Preoperative",
"diagnosis",
"of",
"either",
"presumed",
"first-time",
"low",
"or",
"high",
"grade",
"glioma",
",",
"or",
"recurrent",
"glioma",
",",
"or",
"metastasis",
",",
"or",
"meningioma"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
0,
0,
3
] |
NCT01904136 | 1:31:cancer,110:119:treatment,,136:162:treatment | Chronic myeloid leukemia (CML): a. failed to achieve cytogenetic remission or have cytogenetic relapse after treatment with at least 2 tyrosine kinase inhibitors, or b. accelerated phase or blast phase at any time | 2 | [
"Chronic",
"myeloid",
"leukemia",
"(",
"CML",
")",
":",
"a.",
"failed",
"to",
"achieve",
"cytogenetic",
"remission",
"or",
"have",
"cytogenetic",
"relapse",
"after",
"treatment",
"with",
"at",
"least",
"2",
"tyrosine",
"kinase",
"inhibitors",
",",
"or",
"b.",
... | [
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01959425 | 5:20:treatment,,59:94:treatment,114:128:treatment,130:139:treatment,145:157:treatment,161:207:treatment | Any cardiac surgery within the past 60 days (2 months) or valvular cardiac surgical procedure at any time (i.e., ventriculotomy, atriotomy, and valve repair or replacement and presence of a prosthetic valve) | 2 | [
"Any",
"cardiac",
"surgery",
"within",
"the",
"past",
"60",
"days",
"(",
"2",
"months",
")",
"or",
"valvular",
"cardiac",
"surgical",
"procedure",
"at",
"any",
"time",
"(",
"i.e.",
",",
"ventriculotomy",
",",
"atriotomy",
",",
"and",
"valve",
"repair",
"or... | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
1,
1,
0
] |
NCT01461837 | ,56:75:chronic_disease | Patients must demonstrate one or more of the following Sickle Cell Disease Complications | 2 | [
"Patients",
"must",
"demonstrate",
"one",
"or",
"more",
"of",
"the",
"following",
"Sickle",
"Cell",
"Disease",
"Complications"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT02966444 | 12:21:chronic_disease,25:42:chronic_disease,44:70:chronic_disease | Reports of metabolic or endocrine disease, gastrointestinal disorders, or history of medical or surgical events | 2 | [
"Reports",
"of",
"metabolic",
"or",
"endocrine",
"disease",
",",
"gastrointestinal",
"disorders",
",",
"or",
"history",
"of",
"medical",
"or",
"surgical",
"events"
] | [
0,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02670044 | 16:47:treatment | Ineligible for allogeneic stem cell transplant | 2 | [
"Ineligible",
"for",
"allogeneic",
"stem",
"cell",
"transplant"
] | [
0,
0,
1,
1,
1,
1
] |
NCT02457845 | 47:56:treatment,83:101:treatment,103:116:treatment,120:138:treatment | Patients must have fully recovered from acute treatment related toxicities of all prior chemotherapy, immunotherapy or radiotherapy prior to entering this study | 2 | [
"Patients",
"must",
"have",
"fully",
"recovered",
"from",
"acute",
"treatment",
"related",
"toxicities",
"of",
"all",
"prior",
"chemotherapy",
",",
"immunotherapy",
"or",
"radiotherapy",
"prior",
"to",
"entering",
"this",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0
] |
NCT01415882 | ,69:97:treatment | Recovered (i.e., < grade 1 toxicity) from the reversible effects of prior antineoplastic therapy | 2 | [
"Recovered",
"(",
"i.e.",
",",
"<",
"grade",
"1",
"toxicity",
")",
"from",
"the",
"reversible",
"effects",
"of",
"prior",
"antineoplastic",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02891850 | 10:60:chronic_disease | Relevant obstructive and restrictive or other lung diseases | 2 | [
"Relevant",
"obstructive",
"and",
"restrictive",
"or",
"other",
"lung",
"diseases"
] | [
0,
2,
2,
2,
2,
2,
2,
2
] |
NCT02162420 | 1:22:treatment | transfusion dependent | 2 | [
"transfusion",
"dependent"
] | [
1,
1
] |
NCT03157167 | 11:23:cancer,24:36:chronic_disease,42:47:chronic_disease | Confirmed cutaneous KS/oral lesions with edema | 2 | [
"Confirmed",
"cutaneous",
"KS/oral",
"lesions",
"with",
"edema"
] | [
0,
3,
2,
2,
0,
2
] |
NCT03033498 | ,,60:74:treatment, | Donation or loss of 550 mL or more blood volume (including plasmapheresis) or receipt of a transfusion of any blood product within 8 weeks prior to initial study drug administration | 2 | [
"Donation",
"or",
"loss",
"of",
"550",
"mL",
"or",
"more",
"blood",
"volume",
"(",
"including",
"plasmapheresis",
")",
"or",
"receipt",
"of",
"a",
"transfusion",
"of",
"any",
"blood",
"product",
"within",
"8",
"weeks",
"prior",
"to",
"initial",
"study",
"d... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02830360 | 7:28:chronic_disease | Prior Myocardial Infarction | 2 | [
"Prior",
"Myocardial",
"Infarction"
] | [
0,
2,
2
] |
NCT02129348 | 31:44:chronic_disease,46:70:chronic_disease,78:87:chronic_disease,92:110:chronic_disease | Current clinical diagnosis of schizophrenia, schizoaffective disorder, other psychosis, or bipolar 1 disorder (DSM-IV TR criteria) | 2 | [
"Current",
"clinical",
"diagnosis",
"of",
"schizophrenia",
",",
"schizoaffective",
"disorder",
",",
"other",
"psychosis",
",",
"or",
"bipolar",
"1",
"disorder",
"(",
"DSM-IV",
"TR",
"criteria",
")"
] | [
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT00975520 | 51:68:treatment,77:94:treatment,116:133:chronic_disease | Intercurrent illness that will interfere with the radiation therapy such as immunosuppression due to medication or medical condition | 2 | [
"Intercurrent",
"illness",
"that",
"will",
"interfere",
"with",
"the",
"radiation",
"therapy",
"such",
"as",
"immunosuppression",
"due",
"to",
"medication",
"or",
"medical",
"condition"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
2,
2
] |
NCT02403323 | 33:68:treatment | Patients previously enrolled in etrolizumab Phase III study GA29144 who meet the eligibility criteria for open-label etrolizumab as described in the protocol | 2 | [
"Patients",
"previously",
"enrolled",
"in",
"etrolizumab",
"Phase",
"III",
"study",
"GA29144",
"who",
"meet",
"the",
"eligibility",
"criteria",
"for",
"open-label",
"etrolizumab",
"as",
"described",
"in",
"the",
"protocol"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03089515 | 7:27:chronic_disease | Known prostate hyperplasia | 2 | [
"Known",
"prostate",
"hyperplasia"
] | [
0,
2,
2
] |
NCT02495168 | 40:52:treatment | Once-a-day controlled-release forms of theophylline: 36 hours | 2 | [
"Once-a-day",
"controlled-release",
"forms",
"of",
"theophylline",
":",
"36",
"hours"
] | [
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02121158 | 23:36:chronic_disease | NYHA class II and III heart failure | 2 | [
"NYHA",
"class",
"II",
"and",
"III",
"heart",
"failure"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02056873 | 43:69:treatment,, | Must be at minimum a single trial with an alpha-2 adrenergic agonist (0.1-0.3 mg/day) | 2 | [
"Must",
"be",
"at",
"minimum",
"a",
"single",
"trial",
"with",
"an",
"alpha-2",
"adrenergic",
"agonist",
"(",
"0.1-0.3",
"mg/day",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02100722 | 24:44:treatment, | Inability to take dual antiplatelet therapy for six months | 2 | [
"Inability",
"to",
"take",
"dual",
"antiplatelet",
"therapy",
"for",
"six",
"months"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT01841333 | 5:34:treatment,, | For non-myeloablative transplants, ≥50% CD3 donor chimerism at screening | 2 | [
"For",
"non-myeloablative",
"transplants",
",",
"≥50",
"%",
"CD3",
"donor",
"chimerism",
"at",
"screening"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01822522 | 16:28:treatment,151:169:treatment,205:216:treatment,,, | The effects of cabozantinib on the developing human fetus are unknown; for this reason and because tyrosine kinase inhibitors agents as well as other therapeutic agents used in this trial are known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception prior to study entry ... | 2 | [
"The",
"effects",
"of",
"cabozantinib",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
";",
"for",
"this",
"reason",
"and",
"because",
"tyrosine",
"kinase",
"inhibitors",
"agents",
"as",
"well",
"as",
"other",
"therapeutic",
"agents",
"used",
"... | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01293214 | 1:18:cancer | Active malignancy | 2 | [
"Active",
"malignancy"
] | [
3,
3
] |
NCT02257424 | 20:80:treatment,87:96:treatment,98:111:treatment,113:126:treatment,128:137:treatment,141:154:treatment,,197:206:treatment | Patients receiving cytochrome P450 enzyme-inducing anticonvulsant drugs (EIADs) (i.e. phenytoin, carbamazepine, Phenobarbital, primidone or oxcarbazepine) within 4 weeks of the start of the study treatment | 2 | [
"Patients",
"receiving",
"cytochrome",
"P450",
"enzyme-inducing",
"anticonvulsant",
"drugs",
"(",
"EIADs",
")",
"(",
"i.e",
".",
"phenytoin",
",",
"carbamazepine",
",",
"Phenobarbital",
",",
"primidone",
"or",
"oxcarbazepine",
")",
"within",
"4",
"weeks",
"of",
... | [
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02340650 | 13:22:allergy_name | Person with Lidocaine sensitivity | 2 | [
"Person",
"with",
"Lidocaine",
"sensitivity"
] | [
0,
0,
4,
0
] |
NCT03051282 | 45:52:treatment, | habitual consumption of large quantities of ethanol (>3 drinks/day) | 2 | [
"habitual",
"consumption",
"of",
"large",
"quantities",
"of",
"ethanol",
"(",
">",
"3",
"drinks/day",
")"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02046330 | 1:32:chronic_disease | Major Depression Disorder (MDD) diagnosed by Structured Clinical Interview for DSM-IV (SCID I/DSM-IV), judged to be of disabling severity | 2 | [
"Major",
"Depression",
"Disorder",
"(",
"MDD",
")",
"diagnosed",
"by",
"Structured",
"Clinical",
"Interview",
"for",
"DSM-IV",
"(",
"SCID",
"I/DSM-IV",
")",
",",
"judged",
"to",
"be",
"of",
"disabling",
"severity"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02737930 | 51:57:chronic_disease | Current use of a medication likely to impair post-stroke recovery | 2 | [
"Current",
"use",
"of",
"a",
"medication",
"likely",
"to",
"impair",
"post-stroke",
"recovery"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02541565 | 17:30:cancer | Have measurable nodal disease | 2 | [
"Have",
"measurable",
"nodal",
"disease"
] | [
0,
0,
3,
3
] |
NCT02451553 | 1:14:treatment,7:14:treatment,,46:61:treatment | Major surgery within 4 weeks before starting study treatment or scheduled for surgery during the projected course of the study | 2 | [
"Major",
"surgery",
"within",
"4",
"weeks",
"before",
"starting",
"study",
"treatment",
"or",
"scheduled",
"for",
"surgery",
"during",
"the",
"projected",
"course",
"of",
"the",
"study"
] | [
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02465034 | 31:37:chronic_disease | Individuals with a first time stroke that affects the corona radiata and/or internal capsule | 2 | [
"Individuals",
"with",
"a",
"first",
"time",
"stroke",
"that",
"affects",
"the",
"corona",
"radiata",
"and/or",
"internal",
"capsule"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02207439 | 1:16:treatment,1:17:treatment,19:32:treatment,34:47:treatment,65:74:treatment,76:94:treatment,95:104:treatment,106:121:treatment,123:133:treatment,135:145:treatment,147:156:treatment,158:165:treatment,167:187:treatment,189:201:treatment,203:215:treatment,217:236:treatment,238:250:treatment,251:261:treatment,263:272:tre... | Anti-Convulsants: carbamazepine, Phenobarbital, Anti-Convulsant:phenytoin, Anti-Mycobacterial:rifabutin, PDE5 Inhibitors: sildenafil, vardenafil, tadalafil, HMG-CoA: Reductase Inhibitors: atorvastatin, rosuvastatin, Immuno-suppressants: cyclosporine,tacrolimus, sirolimus, Narcotic Analgesic: methadone, Oral Contracepti... | 2 | [
"Anti-Convulsants",
":",
"carbamazepine",
",",
"Phenobarbital",
",",
"Anti-Convulsant",
":",
"phenytoin",
",",
"Anti-Mycobacterial",
":",
"rifabutin",
",",
"PDE5",
"Inhibitors",
":",
"sildenafil",
",",
"vardenafil",
",",
"tadalafil",
",",
"HMG-CoA",
":",
"Reductase"... | [
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
0,
1,
0,
1,
1,
1,
0,
1,
0,
1
] |
NCT03131960 | 12:30:chronic_disease | History of hemorrhagic stroke | 2 | [
"History",
"of",
"hemorrhagic",
"stroke"
] | [
0,
0,
2,
2
] |
NCT02539160 | 1:13:treatment,15:27:treatment,29:41:treatment,43:57:treatment,59:69:treatment,71:80:treatment,82:92:treatment,94:104:treatment,106:115:treatment,117:127:treatment,132:145:treatment | ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin | 2 | [
"ketoconazole",
",",
"itraconazole",
",",
"voriconazole",
",",
"clarithromycin",
",",
"nefazodone",
",",
"ritonavir",
",",
"saquinavir",
",",
"nelfinavir",
",",
"indinavir",
",",
"atazanavir",
"and",
"telithromycin"
] | [
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT03008408 | 32:45:chronic_disease | Patient has a known history of HIV infection (testing not mandatory) | 2 | [
"Patient",
"has",
"a",
"known",
"history",
"of",
"HIV",
"infection",
"(",
"testing",
"not",
"mandatory",
")"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02657993 | 16:31:treatment,44:48:treatment,50:66:treatment,71:100:treatment, | Current use of corticosteroids, defined as oral, intravenous (IV), or injections of corticosteroids in the past 4 weeks | 2 | [
"Current",
"use",
"of",
"corticosteroids",
",",
"defined",
"as",
"oral",
",",
"intravenous",
"(",
"IV",
")",
",",
"or",
"injections",
"of",
"corticosteroids",
"in",
"the",
"past",
"4",
"weeks"
] | [
0,
0,
0,
1,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02356848 | ,24:39:chronic_disease | Adults (21 years) with Type 2 diabetes | 2 | [
"Adults",
"(",
"21",
"years",
")",
"with",
"Type",
"2",
"diabetes"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02167022 | 1:11:chronic_disease | spastic CP confirmed by a pediatric neurologist or pediatric rehabilitation specialist | 2 | [
"spastic",
"CP",
"confirmed",
"by",
"a",
"pediatric",
"neurologist",
"or",
"pediatric",
"rehabilitation",
"specialist"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02481310 | 55:66:treatment | Patients who have a known allergy to any of the study medications, their analogues, or excipients in the various formulations of any agent | 2 | [
"Patients",
"who",
"have",
"a",
"known",
"allergy",
"to",
"any",
"of",
"the",
"study",
"medications",
",",
"their",
"analogues",
",",
"or",
"excipients",
"in",
"the",
"various",
"formulations",
"of",
"any",
"agent"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01312857 | 1:17:chronic_disease,19:26:chronic_disease,28:50:chronic_disease | Active infection, ascites, hepatic encephalopathy | 2 | [
"Active",
"infection",
",",
"ascites",
",",
"hepatic",
"encephalopathy"
] | [
2,
2,
0,
2,
0,
2,
2
] |
NCT03008408 | 30:50:treatment,,146:158:treatment,160:177:treatment,179:201:treatment | Patients currently receiving anticancer therapies or who have received anticancer therapies within 4 weeks of the start of study drug (including chemotherapy, radiation therapy, antibody based therapy, etc | 2 | [
"Patients",
"currently",
"receiving",
"anticancer",
"therapies",
"or",
"who",
"have",
"received",
"anticancer",
"therapies",
"within",
"4",
"weeks",
"of",
"the",
"start",
"of",
"study",
"drug",
"(",
"including",
"chemotherapy",
",",
"radiation",
"therapy",
",",
... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
1,
0,
0
] |
NCT01643460 | ,,77:101:treatment | Patients referred between January 2009 and February 2016 to EUS at IUMC for pancreatic cyst ablation and with no contraindications for anticipated safe and successful performance of the procedure | 2 | [
"Patients",
"referred",
"between",
"January",
"2009",
"and",
"February",
"2016",
"to",
"EUS",
"at",
"IUMC",
"for",
"pancreatic",
"cyst",
"ablation",
"and",
"with",
"no",
"contraindications",
"for",
"anticipated",
"safe",
"and",
"successful",
"performance",
"of",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01918683 | 1:32:treatment,34:37:treatment,42:58:treatment | Prior TACE to the target lesion, RFA, or liver transplant | 2 | [
"Prior",
"TACE",
"to",
"the",
"target",
"lesion",
",",
"RFA",
",",
"or",
"liver",
"transplant"
] | [
1,
1,
1,
1,
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02013492 | ,36:61:cancer,,,179:207:treatment,211:243:treatment,262:271:chronic_disease,275:299:chronic_disease | At least one solid liver lesion or vascular tumor thrombosis (involving portal vein, IVC and/or hepatic vein) > 1 cm with arterial enhancement and delayed washout on multiphasic computerized tomography (CT) or magnetic resonance imaging (MRI) in the setting of cirrhosis or chronic hepatitis B or C without cirrhosis | 2 | [
"At",
"least",
"one",
"solid",
"liver",
"lesion",
"or",
"vascular",
"tumor",
"thrombosis",
"(",
"involving",
"portal",
"vein",
",",
"IVC",
"and/or",
"hepatic",
"vein",
")",
">",
"1",
"cm",
"with",
"arterial",
"enhancement",
"and",
"delayed",
"washout",
"on",... | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02978443 | 28:44:cancer,81:88:treatment,92:101:treatment,,175:183:treatment,187:195:treatment | Patients with a history of brain metastases must have completed treatment (i.e. surgery or radiation) 1 month prior to enrollment and have no evidence of disease or edema on brain CT or head MRI | 2 | [
"Patients",
"with",
"a",
"history",
"of",
"brain",
"metastases",
"must",
"have",
"completed",
"treatment",
"(",
"i.e",
".",
"surgery",
"or",
"radiation",
")",
"1",
"month",
"prior",
"to",
"enrollment",
"and",
"have",
"no",
"evidence",
"of",
"disease",
"or",
... | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02471833 | 1:9:chronic_disease | Dementia | 2 | [
"Dementia"
] | [
2
] |
NCT03058783 | 1:20:cancer, | carcinoma of cervix effectively treated more than 5 years ago | 2 | [
"carcinoma",
"of",
"cervix",
"effectively",
"treated",
"more",
"than",
"5",
"years",
"ago"
] | [
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02016430 | 18:38:treatment,42:51:treatment,60:75:treatment,79:85:treatment | Having undergone bariatric procedures or surgeries such as gastric banding or bypass | 2 | [
"Having",
"undergone",
"bariatric",
"procedures",
"or",
"surgeries",
"such",
"as",
"gastric",
"banding",
"or",
"bypass"
] | [
0,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
1
] |
NCT02471911 | 29:41:cancer,54:70:cancer,,121:131:cancer,133:168:cancer,173:204:cancer,208:214:cancer | Patients who have had prior malignancies (other than B-cell lymphomas) for ≤5 years with exception of currently treated basal cell, squamous cell carcinoma of the skin, or carcinoma in situ of the cervix or breast | 2 | [
"Patients",
"who",
"have",
"had",
"prior",
"malignancies",
"(",
"other",
"than",
"B-cell",
"lymphomas",
")",
"for",
"≤5",
"years",
"with",
"exception",
"of",
"currently",
"treated",
"basal",
"cell",
",",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
... | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02522715 | 23:35:treatment,39:46:treatment,56:84:treatment | may not have received enzalutamide or ARN-509 (another androgen receptor antagonist) in the past | 2 | [
"may",
"not",
"have",
"received",
"enzalutamide",
"or",
"ARN-509",
"(",
"another",
"androgen",
"receptor",
"antagonist",
")",
"in",
"the",
"past"
] | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT02587962 | 62:88:cancer,145:153:cancer,157:167:cancer,186:193:treatment,290:302:cancer,311:337:cancer | Patients must have histologically or cytologically confirmed carcinoma of the esophagus including the gastroesophageal junction that is locally advanced or metastatic with no available therapy options that are known to provide clinical benefit per institutional standard of care. (various solid tumors cohort, gastroesop... | 2 | [
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"carcinoma",
"of",
"the",
"esophagus",
"including",
"the",
"gastroesophageal",
"junction",
"that",
"is",
"locally",
"advanced",
"or",
"metastatic",
"with",
"no",
"available",
"therapy",
... | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
3,
3,
0,
0,
0,
3,
0,
3,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT01940094 | 1:11:treatment,, | Prednisone dose at time of enrollment of ≥ 5 mg/day and ≤ 20 mg/day | 2 | [
"Prednisone",
"dose",
"at",
"time",
"of",
"enrollment",
"of",
"≥",
"5",
"mg/day",
"and",
"≤",
"20",
"mg/day"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01883076 | ,71:104:treatment | Any condition requiring urgent, or unplanned procedure within 15 days prior to Stage II surgical repair | 2 | [
"Any",
"condition",
"requiring",
"urgent",
",",
"or",
"unplanned",
"procedure",
"within",
"15",
"days",
"prior",
"to",
"Stage",
"II",
"surgical",
"repair"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT03181126 | 1:16:treatment, | Steroid therapy for anti-neoplastic intent within 5 days | 2 | [
"Steroid",
"therapy",
"for",
"anti-neoplastic",
"intent",
"within",
"5",
"days"
] | [
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02323880 | 57:64:treatment | Parts B and C: Patients must have measurable disease on imaging | 2 | [
"Parts",
"B",
"and",
"C",
":",
"Patients",
"must",
"have",
"measurable",
"disease",
"on",
"imaging"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02352467 | 35:51:allergy_name,53:69:allergy_name,71:79:allergy_name,81:94:allergy_name,103:129:allergy_name | Subjects known to be sensitive to Aurix components (calcium chloride, thrombin, ascorbic acid) and/or materials of bovine origin | 2 | [
"Subjects",
"known",
"to",
"be",
"sensitive",
"to",
"Aurix",
"components",
"(",
"calcium",
"chloride",
",",
"thrombin",
",",
"ascorbic",
"acid",
")",
"and/or",
"materials",
"of",
"bovine",
"origin"
] | [
0,
0,
0,
0,
0,
0,
4,
4,
0,
4,
4,
0,
4,
0,
4,
4,
0,
0,
4,
4,
4,
4
] |
NCT02538484 | 1:9:chronic_disease | Cachexia | 2 | [
"Cachexia"
] | [
2
] |
NCT02266719 | 1:11:chronic_disease,15:29:chronic_disease,,,44:77:chronic_disease, | Juxtarenal or suprarenal AAA and type I-IV thoracoabdominal aortic aneurysms with diameter ≥5.0 cm in diameter or 2 times the normal aortic diameter | 2 | [
"Juxtarenal",
"or",
"suprarenal",
"AAA",
"and",
"type",
"I-IV",
"thoracoabdominal",
"aortic",
"aneurysms",
"with",
"diameter",
"≥5.0",
"cm",
"in",
"diameter",
"or",
"2",
"times",
"the",
"normal",
"aortic",
"diameter"
] | [
2,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00967785 | 1:14:chronic_disease,, | Renal failure (calculated creatinine clearance [CrCl] <15 mL/min or requiring dialysis) | 2 | [
"Renal",
"failure",
"(",
"calculated",
"creatinine",
"clearance",
"[",
"CrCl",
"]",
"<",
"15",
"mL/min",
"or",
"requiring",
"dialysis",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02530463 | 1:16:treatment,28:52:treatment,56:94:treatment | Current therapy with other systemic anti-neoplastic or anti-neoplastic investigational agents | 2 | [
"Current",
"therapy",
"with",
"other",
"systemic",
"anti-neoplastic",
"or",
"anti-neoplastic",
"investigational",
"agents"
] | [
1,
1,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT03152409 | 10:30:chronic_disease | Comorbid autoimmune condition | 2 | [
"Comorbid",
"autoimmune",
"condition"
] | [
0,
2,
2
] |
NCT02378428 | 21:33:treatment | Patients who are on hemodialysis | 2 | [
"Patients",
"who",
"are",
"on",
"hemodialysis"
] | [
0,
0,
0,
0,
1
] |
NCT00919503 | 290:293:chronic_disease | DONOR: Unrelated Umbilical Cord Blood: Any cord blood units that have not passed donor screening for infectious disease markers as recommended by NMDP will not be used unless a waiver is signed by the clinical attending allowing use of cord blood unit; cord blood units are presumed to be CMV negative regardless of sero... | 2 | [
"DONOR",
":",
"Unrelated",
"Umbilical",
"Cord",
"Blood",
":",
"Any",
"cord",
"blood",
"units",
"that",
"have",
"not",
"passed",
"donor",
"screening",
"for",
"infectious",
"disease",
"markers",
"as",
"recommended",
"by",
"NMDP",
"will",
"not",
"be",
"used",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02140255 | 20:33:chronic_disease | Confirmed in utero HIV infection | 2 | [
"Confirmed",
"in",
"utero",
"HIV",
"infection"
] | [
0,
0,
0,
2,
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.